Physician duties · PharmD · New York

Signing for a Pharmacist in New York: what the physician takes on

The agreement is mandatory for the clinician, which makes its duties mandatory for you. New York calls the instrument a Collaborative Drug Therapy Management Framework.

Practice authorityConditional independence
Written agreementAgreement required
What New York calls itCollaborative Drug Therapy Management Framework
Governing boardNew York State Education Department, State Board for Pharmacy
Agreement familyCollaborative Practice
Research date2026-08-14 · clauses 2026-09-03

Two narrow, gated pathways, not general independent prescribing: Collaborative Drug Therapy Management (facility-limited to hospitals/nursing homes with on-site pharmacy — NOT community/retail pharmacy) and immunization administration. NY has NOT enacted broader test-and-treat authority — a 2023-24 bill died in committee; its 2025-26 successor remains pending.

Independent practice requires: Certified under §6801-a Collaborative Drug Therapy Management (CDTM) — facility-limited to teaching hospitals, general hospitals, and nursing homes with an on-site pharmacy; requires SED-approved credentialing (PharmD/MS + 2 yrs incl. 1 yr clinical, or BS + 3 of last 7 yrs incl. 1 yr clinical) plus residency training or board certification; OR certified as an immunizer (§§6801/6802/6909) with an SED certificate of administration, acting under a patient-specific physician/NP order OR a non-patient-specific statewide Commissioner standing order during public health threats.

What you take on as the physician

The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.

Proximity

Collaborative Drug Therapy Management (CDTM): On-site presence required

Coded ON_SITE in the narrow sense that §6801-a/8 NYCRR §63.10 require the collaborating physician to practice at the SAME FACILITY as the pharmacist — this is a facility-affiliation requirement, not a real-time physical-presence-during-each-act rule the way a strict on-site standard would be.

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Separate prescribing terms required · no controlled-substance authority

Neither §6801-a nor 8 NYCRR §63.10 contains an explicit controlled-substance carve-out or restriction — this is a genuine statutory gap, not a confirmed prohibition. Coded False here as the more conservative reading (initiating/adjusting Schedule II-V therapy isn't among CDTM's enumerated adjustment powers absent express authorization), but flag for direct legal confirmation before relying on this.

Written agreement

Required

True for CDTM (written protocol with a specific participating physician at the SAME facility, plus SED certification) and for patient-specific-order immunizations; the outbreak/public-health-threat immunization pathway substitutes a state Commissioner standing order for an individual physician agreement.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — Unlike the common assumption that NY restricts pharmacy ownership to licensed pharmacists, §6808 explicitly contemplates non-pharmacist ownership: if the pharmacy's owner isn't a licensed pharmacist, the registration must additionally bear the name of the licensed pharmacist with personal supervision of the pharmacy. The only ownership-linked requirement is a 'good moral character' screen extending to officers/directors and 10%+ stockholders — not a licensure requirement. Operational (not ownership) control requires a pharmacist's 'immediate supervision and management' whenever the pharmacy is open, and no pharmacist may personally supervise more than one pharmacy at a time.

No separate corporate-practice-of-pharmacy statute imposing an ownership restriction was found, despite this being commonly asserted by secondary/law-firm sources characterizing NY's general CPOM strictness as extending to pharmacy — that broader claim appears unsupported by §6808's actual text.

Legal sources for these rules (7)
The document: Collaborative Drug Therapy Management Framework
What a New York Collaborative Drug Therapy Management Framework must contain, who governs it and who signs: read the Collaborative Drug Therapy Management Framework page on practiceagreement.com.

What physicians charge for this role

Typical monthly compensation in New York

$500$600

Estimate for one Pharmacist. Standard-tier state.

About New York's rules

New York combines an unusually strict general corporate-practice-of-medicine regime (physician/same-profession-only PC/PLLC ownership) with two notable exceptions: pharmacy ownership is NOT restricted to pharmacists (Educ. Law §6808), and midwifery (CNM) is its own fully independent practice act (Art. 140), unlike the physician-collaboration model governing NP/PMHNP. CRNA has no dedicated practice statute at all — governed only by DOH facility regulation. NP/PMHNP independence (≥3,600 hours) is a repeatedly-extended sunset provision (currently through July 1, 2030), not permanent law.

Other clinicians in New York: see the state overview.